checkAd

     482  0 Kommentare Launch of Alcon Experience Academy Reinforces Commitment to Training and Education for Eye Care Professionals - Seite 4

    About Alcon
    Alcon is the global leader in eye care. As a division of Novartis, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our products touch the lives of more than 260 million people each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors, and there are millions more who are waiting for solutions to meet their eye care needs. Our purpose is reimagining eye care, and we do this through innovative products, partnerships with eye care professionals and programs that enhance access to quality eye care. Learn more at www.alcon.com.

    Alcon is on Facebook. Like us at www.facebook.com/AlconEyeCare.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Novartis AG!
    Long
    86,66€
    Basispreis
    0,73
    Ask
    × 14,21
    Hebel
    Short
    99,99€
    Basispreis
    0,79
    Ask
    × 12,49
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    About Novartis
    Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis products reach nearly 1 billion people globally and we are finding innovative ways to expand access to our latest treatments. About 125 000 people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com.

    Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis
    For Novartis multimedia content, please visit www.novartis.com/news/media-library
    For questions about the site or required registration, please contact media.relations@novartis.com

    # # #

    Novartis Media Relations
    Central media line: +41 61 324 2200
    E-mail: media.relations@novartis.com

    Eric Althoff
    Novartis Global Media Relations
    +41 61 324 7999 (direct)
    +41 79 593 4202 (mobile)
    eric.althoff@novartis.com
    Wes Warnock
    Alcon Global Communications
    +1 817 615 2501 (direct)
    +1 210 240 4998 (mobile)
    wes.warnock@alcon.com

    Novartis Investor Relations
    Central investor relations line: +41 61 324 7944
    E-mail: investor.relations@novartis.com

    Central   North America  
    Samir Shah +41 61 324 7944 Richard Pulik +1 212 830 2448
    Pierre-Michel Bringer +41 61 324 1065 Cory Twining +1 212 830 2417
    Thomas Hungerbuehler +41 61 324 8425    
    Isabella Zinck +41 61 324 7188    
    Seite 4 von 5


    Diskutieren Sie über die enthaltenen Werte


    GlobeNewswire
    0 Follower
    Autor folgen

    Verfasst von GlobeNewswire
    Launch of Alcon Experience Academy Reinforces Commitment to Training and Education for Eye Care Professionals - Seite 4 Novartis International AG / Launch of Alcon Experience Academy Reinforces Commitment to Training and Education for Eye Care Professionals . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content …

    Schreibe Deinen Kommentar

    Disclaimer